CN Patent

CN118766886A — 达托霉素制剂

Assigned to Xellia Pharmaceuticals ApS · Expires 2024-10-15 · 2y expired

What this patent protects

本发明涉及达托霉素制剂。具体地，本发明涉及包含达托霉素和至少一种氨基酸的组合物，提供这种组合物的方法及其用途。

USPTO Abstract

本发明涉及达托霉素制剂。具体地，本发明涉及包含达托霉素和至少一种氨基酸的组合物，提供这种组合物的方法及其用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN118766886A
Jurisdiction
CN
Classification
—
Expires
2024-10-15
Drug substance claim
No
Drug product claim
No
Assignee
Xellia Pharmaceuticals ApS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.